Fatima Cody Stanford from CMHC and Shasa Hu from LiVDerm as they tackle this complicated issue and field questions from a live audience of curious providers in The Buzz With Newer Weight Loss Treatments: Complications for Cardiometabolic Health, Facial Aging, and Quality of Life
Understanding whether phentermine is a GLP-1 also helps clarify the difference between these drug classes
Hair thinning has been reported, likely related to rapid weight loss rather than the compound itself, as explored in the GLP-1 hair loss guide
Current management focuses on: Lifestyle medications Blood glucose control Cardiovascular risk reduction Patient education Recent research Insight: Source -NICE Guidelines Recent studies have highlighted the growing role of GLP-1 receptor agonists* in improving glycemic control while also supporting weight reduction and cardiovascular protection in selected patients
Neuroprotective Properties Beyond enhancement, Semax provides meaningful neuroprotection
Dr Reddy's Laboratories has obtained regulatory clearance for its semaglutide brand Obeda, and it is also aiming for a dayone entry
